Cxcl7

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Beta-TG; B-TG1; CTAP3; CTAP-II; CTAPIII; CXCL7; C-X-C motif chemokine 7; LA-PF4; LDGF; leukocyte-derived growth factor; MDGF; NAP-2; PBP; PPBP; Pro-platelet basic protein; SCYB7; TC1; TC2; TGB; TGB1; THBGB; THBGB1

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

General informationThis section has been translated automatically.

CXCL7 is a platelet-derived growth factor that belongs to the CXC chemokines. This growth factor is able to activate numerous cellular processes such as DNA synthesis, mitosis activity, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion and the synthesis of hyaluronic acid. CXCL7 can also induce the secretion of plasminogen by synovial cells. CXCL7 also has antimicrobial properties (bactericidal and antifungal). CXCL7 is significantly overexpressed (macrophages) in invasive pulmonary aspergillosis (B44.9) and allergic bronchopulomal aspergillosis (ABPA). CXCL7, together with CXCL4, is significantly overexpressed in the synovial fluidity of "early" rheumatoid arthritis.

CXCL7/CXCR2 and malignancies: A number of studies have shown that the CXCL7/CXCR2 axis plays a role in the processing of malignant tumours, such as lung, kidney, colon and breast cancer. CXCL7 is also overexpressed in cholangiocarcinoma. In colorectal carcinoma, a significant correlation between the level of CXCL7 expression and a poor prognosis could be established. In this context, the observation made in breast carcinoma is interesting that CXCL7 is able to increase the expression of lymphangiogenesis factors VEGF-C/D in target organs.

LiteratureThis section has been translated automatically.

  1. Brown AJ et al(2017) Chemokines CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions. Int J Mol Sci 18. pii: E748. Desurmont T et al (2015) Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival. Cancer Sci 106:262-269.
  2. Guo Q et al(2017) CXCL7 promotes proliferation and invasion of cholangiocarcinoma cells. Oncol Rep 37:1114-1122.
  3. Smith NL et al (2015) Elevated levels of the neutrophil chemoattractant pro-platelet basic protein in macrophages from individuals with chronic and allergic aspergillosis.J Infect Dis 211:651-660.
  4. Unver N et al (2015) CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors. Cytokines 75:330-337.
  5. Yeo L et al (2016) Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis. Ann Rheum Dis 75:763-771.
  6. Yu M et al (2010) CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells. J Oncol 2010:939407.

Authors

Last updated on: 29.10.2020